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A 65-year-old female was admitted with a suspected ST-segment elevation 
myocardial infarction (STEMI) following an acute onset of chest pain and dyspnea, 
and evidence of antero-lateral ST-segment elevation on ECG (Figure 1). She was 
clinically in cardiogenic shock and bedside trans-thoracic echocardiogram (TTE) 
demonstrated a dilated left ventricle (LV) with apical ballooning, overall moderate to 
severe LV systolic dysfunction (LVSD), systolic anterior motion of the mitral valve 
(SAM) and LV outflow tract obstruction (LVOT, Videos 1-2). 
She had a past medical history of hypertension, 5-pack year smoking history and 
a recent diagnosis of hypersensitivity pneumonitis, for which she had received a 3-day 
regime of high-dose pulsed methylprednisolone five days prior to admission as part of a 
clinical trial. She denied any history of physical or psychological stressor. She had a 
previously documented normal LV function on a TTE performed prior to the start of 
intravenous corticosteroids. Emergency cardiac catheterization demonstrated a wrap-
around left anterior descending artery but no obvious occlusion in the coronary tree 
(Figure 2). It also confirmed severe LVSD with apical ballooning. An intra-aortic balloon 
pump (IABP) was inserted and the patient was transferred to coronary care unit for 
supportive management, with furosemide infusion but not inotropic support as this was 
thought to be detrimental in view of the presence of SAM and LVOT on TTE. Routine 
blood tests indicated an inflammatory response and peak troponin was significantly 
elevated at 7992 ng/L (normal range: <16 ng/L). 
 
Autoimmune and virology screens were normal. She subsequently experienced 
recurrent haemoptysis and computed tomography of the thorax showed evidence of 
pulmonary oedema and haemorrhage with underlying pneumonitis (Figure 3). Following 
reviews by the Respiratory and Rheumatology teams and with cautious consideration of 
both risks and benefits, she was commenced on a weaning dose of oral prednisolone 
and over the following days, she made a gradual recovery and both frusemide infusion 
and IABP were discontinued.  Sequential TTEs demonstrated gradually improving LV 
function (Videos 3-4) and a cardiac magnetic resonance imaging (MRI) scan showed a 
normal LV cavity size with severe hypokinesis of the mid anterior, anteroseptal and 
lateral walls and all of the apical segments with the exception of the apical inferoseptum. 
The apical inferoseptum and other segments retained good function resulting in an 
overall normal ejection fraction (Figure 4).  
 
Therefore, a diagnosis of methylprednisolone induced Takotsubo cardiomyopathy 
(TCM) was made, based on the very close temporal relationship between the initiation of 
steroid treatment and patient’s acute illness, the exclusion of any other potential 
triggering factor, normal autoimmune and virology screens, the characteristic regional 
wall motion abnormalities (RWMA) on both TTE and cardiac MRI and the dramatic 
improvement in LV function during the admission following supportive management. She 
was discharged home on beta-blockers and angiotensin converting enzyme-inhibitors 
and remained clinically well on a subsequent follow-up appointment, when a repeat TTE 
confirmed normal LV function and resolution of RWMA. 
 
TCM1, also known as stress cardiomyopathy, apical ballooning syndrome or 
broken heart syndrome, most commonly occurs in post-menopausal women (1) and 
presents with symptoms suggestive of an acute coronary syndrome (2). Other potential 
presentations include Other potential complications include tachy or bradyarrhythmias, 
mitral regurgitation and decompensated heart failure even resulting in cardiogenic shock 
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(3). TCM is more often characterized by transient left apical wall abnormalities both on 
echocardiogram and left ventriculography (4) and is classically preceded by an 
emotional (bereavement, divorce) (5) or physiological (surgery, chemotherapy) (6) 
stressor, although no specific trigger can be identified in up to one-third of cases (7). 
Different theories have been proposed regarding potential underlying etiology and 
mechanisms of TCM and one of the most accredited of these postulates the critical role 
of increased levels of catecholamines secondary to physical or psychological stressors 
and causing acute and transient myocardial toxicity in TCM patients (8,9). However, 
normal catecholamine concentrations were found in a small cohort of patients in a more 
recent study. More recently, the relatively high incidence of TCM in patients with 
subarachnoid hemorrage, epilepsy, electroconvulsive therapy, head injury, stroke, 
anxiety and depression has led to the concept of a neurogenic origin of the coronary 
microcirculation dysfunction responsible for myocardial stunning in TCM (1). Overall, 
such etiological factors result in increased sympathoneural activity, catecholamine-
mediated coronary spasm, direct catecholamine-mediated cardiomyocite dysfunction, 
microvascular dysfunction and myocardial stunning (8), ultimately leading to depressed 
contractile function of the mid and apical walls of the LV with sparing of the basal 
segments, thereby producing the characteristic appearance of the LV. Crucially, regional 
wall motions abnormalities are typically not in a single coronary distribution. Other 
variants have been described, for example with involvement of the base and sparing of 
the apex (inverted or reverse TCM) or with global hypokinesis (10). 
 
Treatment of TCM is conservative and involves supportive measure including 
heart failure management with beta-blockers and/or ACE-I, inotropes if cardiogenic 
shock is present, more rarely LV mechanical support, anticoagulation when LV thrombus 
is identified, and treatment of arrhythmias (11). The prognosis is favourable with full 
resolution of apical wall motion abnormalities in the majority of patients although 
mortality has been reported in up to 8% of patients (12). Recurrence rate is 
approximately 2-10%. Recurrence has been seen in 2-10% of subjects (12). 
 
To our knowledge, this is the first documented case of corticosteroid induced 
TCM: it is possible that, in the absence of any other precipitating factor, the recent 
administration of high-dose intravenous methylprednisolone might have mimicked a 
stress response with subsequent acute LV failure and reversible apical cardiomyopathy.  
Additionally, while STEMI is a relatively common clinical presentation, it is also crucial to 
remain mindful of other potential causes of acute chest pain and dyspnea associated 
with ST-elevation, troponin level rise and clinical evidence of LV failure. Furthermore, 
this case illustrates the importance of a multi-disciplinary approach in similarly complex 
case, leading to successful management of an acutely ill patient. 
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Figure Legends 
 
Figure 1. ECG: evidence of antero-lateral ST-segment elevation  
 
Figure 2. Coronary angiogram: wrap-around left anterior descending artery but no 
obvious occlusion in the coronary tree 
 
Figure 3. Computed tomography of the thorax: evidence of pulmonary oedema and 
haemorrhage with underlying pneumonitis 
 
Figure 4. Cardiac MRI: severe hypokinesis/akinesis of the mid anterior, anteroseptal 
and lateral walls and all of the apical segments, with the exception of the apical 
inferoseptum 
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Figure 1 
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Figure 2 
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Figure 4 
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Highlights 
 
 A case of Iatrogenic corticosteroids induced Takotsubo cardiomyopathy is proposed 
 Takotsubo cardiomyopathy is characterized in the vast majority of cases by transient 
left apical wall abnormalities and is classically preceded by an emotional or 
physiological stressor 
 No specific trigger can be identified in up to one-third of cases of Takotsubo 
cardiomyopathy 
 The role of a multi-disciplinary approach is crucial in the successful management of 
complex cases in which no clear precipitating factor can be promptly identified and a 
careful evaluation of potential risks and benefits of intended treatment is required.  
